Fullerton Health CEO Says AI and Technology Key to Bringing Down Healthcare Costs
Source: The Business Times
Fullerton Health CEO Ho Kuen Loon has identified technology and artificial intelligence as the primary levers for reducing operational costs across the integrated healthcare platform, as the company accelerates its AI deployments after two years of foundational work.
Fullerton Health CEO Ho Kuen Loon has identified technology and artificial intelligence as the primary levers for reducing operational costs across the integrated healthcare platform, as the company accelerates its AI deployments after two years of foundational work. In an interview with The Business Times published June 22, Ho outlined a three-pronged strategy focused on scaling to 10 million lives served, expanding capacity, and offering both online and offline care options with AI as the engine that makes it cost-effective.
The integrated healthcare platform began integrating AI about two years ago and is now stepping up its use to automate administrative workflows, support clinical decision-making, and improve patient triage. Fullerton Health operates across eight markets in Asia and the Pacific including Singapore, Malaysia, Indonesia, Vietnam, Cambodia, China, Hong Kong, and Papua New Guinea. Ho described data as the essential fuel for the AI engine, saying a key focus is getting the right data structure across the disparate units amassed through acquisitions.
The approach reflects a broader trend in Singapore healthcare sector, where hospitals and clinics increasingly turn to AI to manage rising patient volumes and cost pressures. Fullerton strategy mirrors the Singapore government push for more cost-effective and technology-enabled healthcare. With Southeast Asia healthcare spending projected to grow significantly in coming years, platforms that can demonstrate AI-driven cost reduction will have a competitive advantage in winning both patients and investors.
Why it matters for Singapore: Healthcare cost containment is a national priority in Singapore, and AI is increasingly seen as a potential solution. If one of the region largest integrated healthcare platforms can successfully demonstrate that AI deployments meaningfully bring down costs while maintaining care quality, it will provide a compelling case study for the broader healthcare system. The company ambition to serve 10 million lives from its Singapore headquarters also reinforces the city-state position as a base for healthcare AI innovation that scales regionally.